LHC
NVO

Levy Harkins & Co’s Novo Nordisk NVO Stock Holding History

Levy Harkins & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$10.8M Sell
438,510
-31,450
-7% -$826K 2.75% 12
2017
Q4 		$12.6M Sell
469,960
-18,990
-4% -$483K 3.91% 11
2017
Q3 		$11.8M Sell
488,950
-220
-0% -$4.97K 3.87% 10
2017
Q2 		$10.5M Sell
489,170
-8,550
-2% -$173K 3.66% 13
2017
Q1 		$8.53M Sell
497,720
-8,500
-2% -$148K 3.11% 15
2016
Q4 		$9.08M Buy
506,220
+15,300
+3% +$277K 3.47% 13
2016
Q3 		$10.2M Buy
+490,920
New +$12.2M 4.04% 11

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Levy Harkins & Co's NVO Position: Q1 2018 in Review

Levy Harkins & Co reduced its Novo Nordisk (NVO) stake by 6.7% in Q1 2018, selling an estimated $826K and leaving 438,510 shares worth $10.8M. The position accounts for 2.75% of the portfolio, ranked #12.

Levy Harkins & Co first reported a position in NVO in Q3 2016 and has held it in 7 quarters since. The position peaked at $12.6M in Q4 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

  • Levy Harkins & Co held 438,510 shares of Novo Nordisk worth $10.8M as of Q1 2018.
  • Levy Harkins & Co sold 31,450 Novo Nordisk shares in Q1 2018, an estimated $826K.
  • Novo Nordisk made up 2.75% of Levy Harkins & Co's portfolio in Q1 2018, its #12 holding.
  • Levy Harkins & Co first reported a position in Novo Nordisk in Q3 2016 and has held it in 7 quarters since.
  • Levy Harkins & Co's Novo Nordisk position peaked at $12.6M in Q4 2017.
  • 553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Levy Harkins & Co's 13F filing for Q1 2018, filed 26 Apr 2018.